Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis
Nemat Khan,Vinod Kumar,Pengcheng Li,Luregn J. Schlapbach,Andrew W. Boyd,Mark G. Coulthard,Trent M. Woodruff,Luregn J. Schlapbach,Sainath Raman,Natalie Sharp,Natalie Phillips,Adam Irwin,Shane George,Keith Grimwood,Peter Snelling,Arjun Chavan,Allison Hempenstall,Kristen Gibbons,Renate Le Marsney,Antje Blumenthal,Devika Ganesamoorthy,Lachlan Coin,RAPIDS Study Group
DOI: https://doi.org/10.1126/scitranslmed.adg5768
IF: 17.1
2024-04-25
Science Translational Medicine
Abstract:Sepsis is a life-threatening disease caused by a dysregulated host response to infection, resulting in 11 million deaths globally each year. Vascular endothelial cell dysfunction results in the loss of endothelial barrier integrity, which contributes to sepsis-induced multiple organ failure and mortality. Erythropoietin-producing hepatocellular carcinoma (Eph) receptors and their ephrin ligands play a key role in vascular endothelial barrier disruption but are currently not a therapeutic target in sepsis. Using a cecal ligation and puncture (CLP) mouse model of sepsis, we showed that prophylactic or therapeutic treatment of mice with EphA4-Fc, a decoy receptor and pan-ephrin inhibitor, resulted in improved survival and a reduction in vascular leak, lung injury, and endothelial cell dysfunction. EphA2 −/− mice also exhibited reduced mortality and pathology after CLP compared with wild-type mice. Proteomics of plasma samples from mice with sepsis after CLP revealed dysregulation of a number of Eph/ephrins, including EphA2/ephrin A1. Administration of EphA4-Fc to cultured human endothelial cells pretreated with TNF-α or ephrin-A1 prevented loss of endothelial junction proteins, specifically VE-cadherin, with maintenance of endothelial barrier integrity. In children admitted to hospital with fever and suspected infection, we observed that changes in EphA2/ephrin A1 in serum samples correlated with endothelial and organ dysfunction. Targeting Eph/ephrin signaling may be a potential therapeutic strategy to reduce sepsis-induced endothelial dysfunction and mortality.
cell biology,medicine, research & experimental